GH
Price
$46.46
Change
-$0.82 (-1.73%)
Updated
Jul 18 closing price
Capitalization
2.46B
9 days until earnings call
RPID
Price
$3.41
Change
-$0.04 (-1.16%)
Updated
Jul 18 closing price
Capitalization
40.8M
11 days until earnings call
Interact to see
Advertisement

GH vs RPID

Header iconGH vs RPID Comparison
Open Charts GH vs RPIDBanner chart's image
Guardant Health
Price$46.46
Change-$0.82 (-1.73%)
Volume$1.77M
Capitalization2.46B
Rapid Micro Biosystems
Price$3.41
Change-$0.04 (-1.16%)
Volume$22.62K
Capitalization40.8M
GH vs RPID Comparison Chart in %
Loading...
GH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GH vs. RPID commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GH is a Hold and RPID is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (GH: $46.46 vs. RPID: $3.41)
Brand notoriety: GH: Notable vs. RPID: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GH: 92% vs. RPID: 27%
Market capitalization -- GH: $2.46B vs. RPID: $40.8M
GH [@Medical Specialties] is valued at $2.46B. RPID’s [@Medical Specialties] market capitalization is $40.8M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GH’s FA Score shows that 0 FA rating(s) are green whileRPID’s FA Score has 0 green FA rating(s).

  • GH’s FA Score: 0 green, 5 red.
  • RPID’s FA Score: 0 green, 5 red.
According to our system of comparison, both GH and RPID are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GH’s TA Score shows that 4 TA indicator(s) are bullish while RPID’s TA Score has 4 bullish TA indicator(s).

  • GH’s TA Score: 4 bullish, 4 bearish.
  • RPID’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both GH and RPID are a good buy in the short-term.

Price Growth

GH (@Medical Specialties) experienced а -7.54% price change this week, while RPID (@Medical Specialties) price change was +1.49% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.11%. For the same industry, the average monthly price growth was +2.74%, and the average quarterly price growth was -1.25%.

Reported Earning Dates

GH is expected to report earnings on Jul 30, 2025.

RPID is expected to report earnings on Aug 01, 2025.

Industries' Descriptions

@Medical Specialties (-0.11% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GH($2.47B) has a higher market cap than RPID($40.8M). RPID YTD gains are higher at: 278.889 vs. GH (52.079). RPID has higher annual earnings (EBITDA): -53.46M vs. GH (-433.3M). GH has more cash in the bank: 1.17B vs. RPID (92.1M). RPID has less debt than GH: RPID (7.35M) vs GH (1.35B). GH has higher revenues than RPID: GH (564M) vs RPID (22.5M).
GHRPIDGH / RPID
Capitalization2.47B40.8M6,042%
EBITDA-433.3M-53.46M811%
Gain YTD52.079278.88919%
P/E RatioN/A7.80-
Revenue564M22.5M2,507%
Total Cash1.17B92.1M1,269%
Total Debt1.35B7.35M18,432%
FUNDAMENTALS RATINGS
GH: Fundamental Ratings
GH
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GHRPID
RSI
ODDS (%)
Bearish Trend 3 days ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 5 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
GH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNY48.32-0.33
-0.68%
Sanofi ADS
TX30.36-0.32
-1.04%
Ternium SA
TBLA3.54-0.04
-1.12%
Taboola.com Ltd
REFI13.31-0.29
-2.13%
Chicago Atlantic Real Estate Finance
AWRE2.31-0.07
-2.94%
Aware

GH and

Correlation & Price change

A.I.dvisor indicates that over the last year, GH has been loosely correlated with TWST. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if GH jumps, then TWST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GH
1D Price
Change %
GH100%
-1.73%
TWST - GH
50%
Loosely correlated
-1.90%
VCYT - GH
48%
Loosely correlated
-2.93%
NTRA - GH
48%
Loosely correlated
-3.12%
RGEN - GH
44%
Loosely correlated
-6.28%
BLFS - GH
43%
Loosely correlated
-1.00%
More

RPID and

Correlation & Price change

A.I.dvisor tells us that RPID and SDMHF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RPID and SDMHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPID
1D Price
Change %
RPID100%
-1.16%
SDMHF - RPID
30%
Poorly correlated
N/A
BFLY - RPID
30%
Poorly correlated
+1.08%
ISRG - RPID
30%
Poorly correlated
+1.17%
GKOS - RPID
28%
Poorly correlated
-1.31%
GH - RPID
27%
Poorly correlated
-1.73%
More